SCHEMBL31695334

SCHEMBL31695334

N#Cc1c(-c2ccc(O)c(Br)c2)cc(-c2ccc(F)cc2)[nH]c1=N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL4 P05112 1/20 0.43
▸ PIM1 P11309 6/20 0.41
▸ BIRC5 O15392 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MET P08581 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ GCGR P47871 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ ERCC1 P07992 1/20 0.36
▸ ERCC4 Q92889 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29335418 0.89 IL4 (0.54) IL4PIM1BIRC5ALDH1A1MAPT
SCHEMBL31695313 0.89 IL4 (0.54) IL4PIM1BIRC5ALDH1A1MAPT
SCHEMBL31695360 0.86 IL4 (0.43) IL4PIM1BIRC5ALDH1A1MAPT
SCHEMBL31695335 0.83 KDM4E (0.59) IL4PIM1ALDH1A1MAPTKDM4E
SCHEMBL31695352 0.83 ACMSD (0.49) IL4PIM1BIRC5ALDH1A1MAPT
SCHEMBL23920029 0.81 PIM1 (0.47) PIM1BIRC5ALDH1A1MAPTKDM4E
SCHEMBL31695295 0.81 KDM4E (0.48) IL4PIM1ALDH1A1MAPTKDM4E
SCHEMBL23841138 0.80 ATM (0.57) PIM1BIRC5ALDH1A1MAPTKDM4E
SCHEMBL31695348 0.79 PIM1 (0.47) IL4PIM1BIRC5ALDH1A1MAPT
SCHEMBL31695294 0.78 KDR (0.50) PIM1ALDH1A1MAPTKDM4EMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 IL4 1/4885PIM1 585/4885BIRC5 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback